Advancing with science

From a scientific point of view, the 21st century was born under the sign of the brain. While all other organs have been widely researched, we are still a long way off fully understanding the control centre of our bodies. This is not only where the very nucleus of our individuality lies hidden, but also the key to the successful therapy of countless diseases.

This makes the brain with its hundreds of billions of nerve cells an ideal organ for stimulation procedures. Targeted stimulation can help in a wide variety of diseases. In epilepsy, for instance, the areas where the seizures originate or that are in part responsible for the seizure spreading can be reached. Given that in one in three epilepsy patients drugs to control seizures do not ensure adequate disease management, stimulation is an important treatment option.

Advance in cortical brain stimulation

The efficacy of stimulation treatments of the brain has long been recognised. Research has even proven that efficacy improves with long-term use. Where the scientific and technical challenge lies is actually in the type of stimulation. Pharmacoresistant epilepsy patients have so far had to take on board a high level of risk and significant restrictions.

Over the past few years, research has focused on the further development of procedures that can stimulate the cortex of the brain with the aid of customised electrical stimuli. The aim is to achieve deep brain stimulation without a direct procedure on the skull or brain. Precisis AG has achieved an innovative breakthrough with EASEE® with the knowledge gained in studies and the know-how of renowned scientists, surgeons and IT developers.

In Germany, some 800,000 people suffer from epilepsy.


Of those epilepsy patients, about 30% find their condition inadequately managed by drugs.


Brain surgery is recommended in 1% of pharmacoresistant epilepsy patients.


That leaves 29% of patients with pharmacoresistant epilepsy looking for additional technical support.